Unlocking Answers to Your Health

Sema4 is a health information company dedicated to improving the diagnosis, treatment, and prevention of disease through deep data analysis

Our Story

Trust in Sema4

  • Our Story

    Backed by the reputation of Mount Sinai and groundbreaking research from the Icahn School of Medicine Learn More
  • Our Technology

    Six genomic technologies used in parallel to ensure comprehensive and highly accurate screening for genetic conditions Learn More
  • Our Products

    Genetic tests to empower patients and their doctors to make better health decisions, now and in the future Learn More
  • Our Research

    Breakthrough discoveries from our scientists in the fields of genetics and genomics Learn More

News

  •  
    SEMA4 PRESS RELEASE | 12.18.17

    Sema4 Appoints Corporate Development Executive Kareem Saad as Chief Strategy Officer

    “Sema4 today announced the appointment of Kareem Saad as Chief Strategy Officer. Mr. Saad has extensive experience in the healthcare and life sciences sector, where, over the span of a twenty-year career, he has been responsible for developing and implementing strategic execution plans, managing partner businesses, and completing corporate, fundraising and business development transactions worth more than $500 million. At Sema4, he will lead a major push for corporate strategy and growth, working closely with business partners and current as well as prospective investors…”